VIPERGEN R & D III K/S: Financial statements 2015
CVR: 30355644
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -932,000 compared with DKK -12,291,000 the year before. Equity in the 2015 report amounted to DKK 0.
- Revenue
- DKK 0
- Profit/Loss
- DKK -932,000
- Equity
- DKK 0
- Total Assets
- DKK 2,835,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 0 | - | -932K | 0 | - |
| 2014 | 805K | - | -12.3M | 932K | - |
| 2013 | 804K | - | -10.7M | -1.8M | - |
| 2012 | 0 | - | -10.2M | 8.9M | - |
Official annual report
How creditworthy is VIPERGEN R & D III K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
VIPERGEN R & D III K/S has published its annual report for 2014. Revenue came to DKK 805,000, and the net result was DKK -12,291,000.
As of June 11, 2015, Gunnar Kjems is registered as chairman of VIPERGEN R & D III K/S.
As of June 11, 2015, Eigil Bjerl Nielsen has stepped down as chairman of VIPERGEN R & D III K/S.
As of June 10, 2015, Gunnar Kjems has left the board of directors of VIPERGEN R & D III K/S.
As of June 9, 2015, KPMG P/S has been appointed auditor of VIPERGEN R & D III K/S.
As of June 9, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of VIPERGEN R & D III K/S.
About VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.
